澳门广东会(中国·VIP认证)股份有限公司
澳门广东会
TaiGen Biotechnology
0
0
0
About
Overview
Steering Committee
Career
Management Team
Milestones
Board of Directors
About Us
TaiGen is a discovery-based and market-focused pharmaceutical company engaging in the development of novel therapeutics for infectious diseases and other indications with high degree of unmet medical needs.
R&D Center
Pipeline
R&D Progress
Antibiotic
Taigexyn®
Influenza Antiviral
TG-1000
HCV Antiviral
Furaprevir
Stem Cell Mobilizer
Burixafor
Research
R&D Center
TaiGen’s dedicated team of professional scientists perform cutting edge research in drug discovery to advance programs efficiently. Our pipeline of anti-infective & anti-inflammatory programs are the fruits of both internal research as well as in-licensed programs.
News
News
Investors
Investors
Financial Information
Material Information
Material Information
Shareholders' Information
Shareholders' Information
Corporate Governance
Investor FAQs
Investors
Communicating with investors, cultivating long-term investor relations and highlighting corporate’s value.
Business & Partnership
ESG
Contact Us
Home
繁中
Contact
Contact
Subject *
Investors Relations
Research & Development
Business Collaboration
Clinical Trials
Other
Submit
TaiGen Biotechnology Co., Ltd.
7F., No. 138, Xinming Rd., Neihu Dist., Taipei City 11470, Taiwan (R.O.C.)
Tel:
886-2-8177-7020
Fax:
886-2-2796-3606
TaiGen Biopharmaceuticals Co. (Beijing), Ltd.
Suite 2312, A Tower, FULL LINK Building No. 18 Chaoyangmenwaidajie,Beijing 100020, China
Tel:
86-10-65882004
Home
Contact Us
网站首页
澳门广东会